Regina I. Jakacki

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

Jason Fangusaro, Arzu Onar‐Thomas, Tina Young Poussaint et al. · The Lancet Oncology · 2019 · 472 citations · Full text

Neuro-oncology, Tumoral Pathology, Pediatric Brain Tumors +12

Carboplatin and vincristine for recurrent and newly diagnosed low-grade gliomas of childhood.

Roger J. Packer, Beverly J. Lange, J Ater et al. · Journal of Clinical Oncology · 1993 · 354 citations

A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study

Anuradha Banerjee, Regina I. Jakacki, Arzu Onar‐Thomas et al. · Neuro-Oncology · 2017 · 309 citations · Full text

Phase II Study of Weekly Vinblastine in Recurrent or Refractory Pediatric Low-Grade Glioma

Éric Bouffet, Regina I. Jakacki, Stewart Goldman et al. · Journal of Clinical Oncology · 2012 · 223 citations · Full text

Outcome of Children With Metastatic Medulloblastoma Treated With Carboplatin During Craniospinal Radiotherapy: A Children's Oncology Group Phase I/II Study

Regina I. Jakacki, Peter C. Burger, Tianni Zhou et al. · Journal of Clinical Oncology · 2012 · 217 citations · Full text